PODD
Price
$346.76
Change
+$0.30 (+0.09%)
Updated
Sep 5, 02:28 PM (EDT)
Capitalization
24.39B
55 days until earnings call
RSMDF
Price
$16.63
Change
+$0.06 (+0.36%)
Updated
Aug 12 closing price
Capitalization
40.09B
48 days until earnings call
Interact to see
Advertisement

PODD vs RSMDF

Header iconPODD vs RSMDF Comparison
Open Charts PODD vs RSMDFBanner chart's image
Insulet
Price$346.76
Change+$0.30 (+0.09%)
Volume$300
Capitalization24.39B
Resmed
Price$16.63
Change+$0.06 (+0.36%)
Volume$159
Capitalization40.09B
PODD vs RSMDF Comparison Chart in %
Loading...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PODD vs. RSMDF commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PODD is a Buy and RSMDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (PODD: $346.47 vs. RSMDF: $16.57)
Brand notoriety: PODD and RSMDF are both not notable
PODD represents the Medical/Nursing Services, while RSMDF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PODD: 79% vs. RSMDF: 3%
Market capitalization -- PODD: $24.39B vs. RSMDF: $40.09B
PODD [@Medical/Nursing Services] is valued at $24.39B. RSMDF’s [@Pharmaceuticals: Other] market capitalization is $40.09B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PODD’s FA Score shows that 2 FA rating(s) are green whileRSMDF’s FA Score has 1 green FA rating(s).

  • PODD’s FA Score: 2 green, 3 red.
  • RSMDF’s FA Score: 1 green, 4 red.
According to our system of comparison, PODD is a better buy in the long-term than RSMDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PODD’s TA Score shows that 6 TA indicator(s) are bullish while RSMDF’s TA Score has 5 bullish TA indicator(s).

  • PODD’s TA Score: 6 bullish, 4 bearish.
  • RSMDF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PODD is a better buy in the short-term than RSMDF.

Price Growth

PODD (@Medical/Nursing Services) experienced а +2.63% price change this week, while RSMDF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.15%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +24.89%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.56%. For the same industry, the average monthly price growth was +6.80%, and the average quarterly price growth was +18.38%.

Reported Earning Dates

PODD is expected to report earnings on Oct 30, 2025.

RSMDF is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.56% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RSMDF($40.1B) has a higher market cap than PODD($24.4B). PODD has higher P/E ratio than RSMDF: PODD (105.63) vs RSMDF (17.49). PODD YTD gains are higher at: 32.712 vs. RSMDF (-27.058). RSMDF has higher annual earnings (EBITDA): 1.92B vs. PODD (407M). RSMDF has more cash in the bank: 1.21B vs. PODD (1.12B). RSMDF has less debt than PODD: RSMDF (852M) vs PODD (1.4B). RSMDF has higher revenues than PODD: RSMDF (5.15B) vs PODD (2.36B).
PODDRSMDFPODD / RSMDF
Capitalization24.4B40.1B61%
EBITDA407M1.92B21%
Gain YTD32.712-27.058-121%
P/E Ratio105.6317.49604%
Revenue2.36B5.15B46%
Total Cash1.12B1.21B93%
Total Debt1.4B852M164%
FUNDAMENTALS RATINGS
PODD vs RSMDF: Fundamental Ratings
PODD
RSMDF
OUTLOOK RATING
1..100
2031
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
6099
SMR RATING
1..100
4737
PRICE GROWTH RATING
1..100
590
P/E GROWTH RATING
1..100
692
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSMDF's Valuation (30) in the null industry is somewhat better than the same rating for PODD (89) in the Medical Specialties industry. This means that RSMDF’s stock grew somewhat faster than PODD’s over the last 12 months.

PODD's Profit vs Risk Rating (60) in the Medical Specialties industry is somewhat better than the same rating for RSMDF (99) in the null industry. This means that PODD’s stock grew somewhat faster than RSMDF’s over the last 12 months.

RSMDF's SMR Rating (37) in the null industry is in the same range as PODD (47) in the Medical Specialties industry. This means that RSMDF’s stock grew similarly to PODD’s over the last 12 months.

PODD's Price Growth Rating (5) in the Medical Specialties industry is significantly better than the same rating for RSMDF (90) in the null industry. This means that PODD’s stock grew significantly faster than RSMDF’s over the last 12 months.

PODD's P/E Growth Rating (6) in the Medical Specialties industry is significantly better than the same rating for RSMDF (92) in the null industry. This means that PODD’s stock grew significantly faster than RSMDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PODDRSMDF
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
47%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
44%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
29%
MACD
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
43%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
34%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
N/A
Declines
ODDS (%)
Bearish Trend about 1 month ago
67%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
58%
Aroon
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
34%
View a ticker or compare two or three
Interact to see
Advertisement
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AWK141.570.87
+0.62%
American Water Works Company
NCNO30.45-0.17
-0.56%
nCino
SGMO0.53N/A
-0.71%
Sangamo Therapeutics
CANF0.65-0.01
-1.53%
Can-Fite BioPharma Ltd
QD4.49-0.24
-5.07%
Qudian

PODD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PODD has been loosely correlated with ISRG. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PODD
1D Price
Change %
PODD100%
+0.86%
ISRG - PODD
47%
Loosely correlated
+3.02%
BSX - PODD
46%
Loosely correlated
-0.22%
SYK - PODD
42%
Loosely correlated
+1.49%
DXCM - PODD
39%
Loosely correlated
+2.33%
PEN - PODD
39%
Loosely correlated
+3.71%
More

RSMDF and

Correlation & Price change

A.I.dvisor tells us that RSMDF and NAOV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSMDF and NAOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
N/A
NAOV - RSMDF
30%
Poorly correlated
-4.93%
PODD - RSMDF
25%
Poorly correlated
+0.86%
ANIK - RSMDF
25%
Poorly correlated
+0.89%
FLGT - RSMDF
25%
Poorly correlated
-0.18%
PACB - RSMDF
24%
Poorly correlated
-1.59%
More